Cognitive speed training shows potential to delay dementia for two decades Skip to content Menu Medical Home Life Sciences Home Become a Member Search Medical Home Life Sciences Home About Functional Food News Health A-Z Drugs Medical Devices Interviews White Papers More... MediKnowledge eBooks Posters Podcasts Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Top Health Categories Coronavirus Disease COVID-19 Diet & Nutrition Artificial Intelligence Allergies Alzheimer's & Dementia Arthritis & Rheumatology Breast Cancer Breastfeeding Cold, Flu & Cough Dermatology Diabetes Eating Disorders Eye Health Gastrointestinal Health Heart Disease Lung Cancer Mental Health Parkinson's Disease Pregnancy Sleep Urology View Health A-Z × Top Health Categories Coronavirus Disease COVID-19 Eating Disorders Diet & Nutrition Eye Health Artificial Intelligence Gastrointestinal Health Allergies Heart Disease Alzheimer's & Dementia Lung Cancer Arthritis & Rheumatology Mental Health Breast Cancer Parkinson's Disease Breastfeeding Pregnancy Cold, Flu & Cough Sleep Dermatology Urology Diabetes View Health A-Z Medical Home Life Sciences Home About News Life Sciences A-Z White Papers Lab Equipment Interviews Newsletters Webinars More... eBooks Posters Podcasts Contact Meet the Team Advertise Search Become a Member White Papers MediKnowledge eBooks Posters Podcasts Newsletters Health & Personal Care Contact Meet the Team Advertise Search Become a Member Webinars eBooks Posters Podcasts Contact Meet the Team Advertise Search Become a Member Cognitive speed training shows potential to delay dementia for two decades Download PDF Copy Reviewed Johns Hopkins Medicine Feb 9 2026 Adults age 65 and older who completed five to six weeks of cognitive speed training - in this case, speed of processing training, which helps people quickly find visual information on a computer screen and handle increasingly complex tasks in a shorter time period - and who had follow-up sessions about one to three years later were less likely to be diagnosed with dementia, including Alzheimer's disease, up to two decades later, according to new findings published today in Alzheimer's & Dementia: Translational Research and Clinical Interventions . This National Institutes of Health (NIH)-funded study is the first randomized clinical trial, and only study of its kind, to assess 20-year links with dementia, including Alzheimer's disease, among adults who participated in the Advanced Cognitive Training for Independent and Vital Elderly (ACTIVE) study. Investigators enrolled 2,802 adults into this study in 1998–99 to assess long-term benefits of participants randomized to three different types of cognitive training - memory, reasoning and speed of processing - in comparison to a control group who received no training. In the three training groups, participants received up to 10 sessions of 60–75 minutes of cognitive training that took place over five to six weeks. Additionally, half of participants were randomized to receive up to four additional cognitive training sessions, or boosters, which took place 11 and 35 months after the initial training. In this 20-year follow-up study, investigators found that 105 out of 264 (40%) participants in the speed-training group with boosters were diagnosed with dementia, which was a 25% reduced incidence compared to 239 out of 491 (49%) adults in the control arm. This was the only intervention with a statistically significant, or meaningful, difference compared to the control group. To reach these findings, investigators reviewed Medicare data from 2,021 participants (72% of the original study) between 1999 and 2019. Characteristics of participants in the follow-up study were similar to the original trial. Three-fourths of participants were women, 70% were white, and the average age was 74 at the start of the study. During the follow-up period, about three-fourths of participants died (at an average age of 84). Dementia is characterized as declines in thinking that result in the inability of an individual to live independently or manage on their own on a daily basis. It's estimated to affect 42% of adults older than age 55 at some point in their life, and costs the U.S. more than $600 billion each year. Alzheimer's disease, the most common type, accounts for about 60%–80% of dementia cases, while vascular dementia accounts for about 5%–10%. Other types of dementia include Lewy body, frontotemporal or combinations. Seeing that boosted speed training was linked to lower dementia risk two decades later is remarkable because it suggests that a fairly modest nonpharmacological intervention can have long-term effects. Even small delays in the onset of dementia may have a large impact on public health and help reduce rising health care costs." Marilyn Albert, Ph.D., corresponding study author and director of the Alzheimer's Disease Research Center, Johns Hopkins Medicine Albert explained that additional studies are needed to understand underlying mechanisms that may help explain these associations and to understand why the reasoning and memory interventions didn't have the same 20-year associations. Findings from this 20-year study expand on prior research from the ACTIVE trial, which is the largest study in the U.S. to assess different types of cognitive training in adults. ACTIVE researchers previously found that cognitive training helped participants improve everyday tasks involved with thinking, remembering, reasoning and quickly making decisions for up to five years. All three training arms were also linked to improved outcomes with everyday function 10 years later. Additionally, those who completed speed training had a 29% lower incidence of dementia 10 years later compared to the control group. Each booster session was linked to further risk reductions. Related Stories New calculator accurately estimates the risk of dementia after a stroke New report provides updated prevalence figures for the number of people living with dementia Dementia collaborative care delivers greater value than Alzheimer’s medication The authors explain that speed training may have been particularly effective because the program was adaptive – it adapted its level of challenge for each participant's individual performance level that day. People who were faster at the start moved to faster challenges quickly, and people who needed more time started at slower levels. The memory and reasoning programs were not adaptive - everyone in the group learned the same strategies. Additionally, speed training drives implicit learning (more like an unconscious habit or a skill), while memory training and reasoning training drive explicit learning (more like learning facts and strategies). Scientists already know that implicit learning works very differently in the brain than explicit learning, and this may contribute to the results seen with dementia in the current analysis. "Our findings provide support for the development and refinement of cognitive training interventions for older adults, particularly those that target visual processing and divided attention abilities," says site principal investigator George Rebok, Ph.D., a lifespan developmental psychologist who creates community programs for healthy aging and is a professor emeritus of mental health at the Johns Hopkins Bloomberg School of Public Health. "It is possible that adding this cognitive training to lifestyle change interventions may delay dementia onset, but that remains to be studied." The authors also note that speed training may synergistically support other lifestyle interventions that strengthen neural connections, but more research is needed to understand these interactions and to confirm this. Other activities that have been associated with reduced risk of cognitive decline include taking steps to support cardiovascular health, such as monitoring blood pressure, blood sugar, cholesterol and body weight, and engaging in regular physical activity. Additional study authors include Norma B. Coe, Chuxuan Sun and Elizabeth Taggert (University of Pennsylvania), Katherine E. M. Miller and Alden L. Gross (the Johns Hopkins Bloomberg School of Public Health), Richard N. Jones (Brown University), Cynthia Felix (University of Pittsburgh), Michael Marsiske (University of Florida), Karlene K. Ball (University of Alabama at Birmingham) and Sherry L. Willis (University of Washington). This study is funded by NIH grants from the National Institute on Aging (R01AG056486). The original ACTIVE trial was supported by NIH grants to six field sites and the coordinating center. This includes Hebrew Senior-Life, Boston (NR04507), the Indiana University School of Medicine (NR04508), The Johns Hopkins University (AG014260), the New England Research Institutes (AG014282), the Pennsylvania State University (AG14263), the University of Alabama at Birmingham (AG14289) and Wayne State University/University of Florida (AG014276). Source: Johns Hopkins Medicine Journal reference: Coe, N. B., et al . (2026) Impact of cognitive training on claims-based diagnosed dementia over 20 years: evidence from the ACTIVE study. DOI: 10.1002/trc2.70197. https://alz-journals.onlinelibrary.wiley.com/doi/10.1002/trc2.70197 Posted in: Medical Research News | Medical Condition News Comments (0) Download PDF Copy Suggested Reading People with cerebral amyloid angiopathy more likely to develop dementia Family remains central to elder care responsibilities in America Brain protein CUL5 protects neurons by clearing toxic tau clumps Dementia Care Aware partners with IHI to advance age-friendly care Study suggests shingles vaccine may help lower Alzheimer’s and dementia risk A shingles vaccine may delay dementia onset Study identifies link between gut bacteria and deterioration of the brain in ALS, dementia CTE should be recognized as new cause of dementia, study suggests Comments The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical. Cancel reply to comment Post a new comment Login (Logout) Quirky Comment Title Post Trending Stories Latest Interviews Top Health Articles Cognitive speed training shows potential to delay dementia for two decades Gut bacteria use formic acid as an electron taxi Metformin linked to lower odds of intermediate macular degeneration in people with diabetes Influenza D virus and canine coronavirus pose human risks New DNA-based vaccine scaffolds boost targeted immune responses to HIV Advancing brain microphysiological systems (bMPS) Dr. Lena Smirnova Brain microphysiological systems are reshaping in vitro neurotoxicity testing through functional validation and advanced disease modeling. PhD researcher at LifeArc Natasha Bury Targeted protein degradation presents a promising strategy to address antimicrobial resistance, focusing on innovative approaches for gram-negative bacteria. Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research Rosanna Zhang In our latest interview, News-Medical speaks with Rosanna Zhang from ACROBiosystems about utilizing organoids for disease modeling in the field of neuroscience research. Astaxanthin and Human Health: Evidence on Skin, Vision, Brain, and Aging The Gut–Brain–Skin Axis: How Diet and Gut Health Influence Mood, Skin, and Aging How to Safely Return to Exercise After Prolonged Physical Inactivity How Morning Routines Influence Cognitive Performance, Mood, and Circadian Rhythm Dry January: Key Health Benefits of 30 Days Without Alcohol Latest News Shared brainwave biomarker bridges mouse and human fragile X research Economic disadvantage linked to tobacco addiction and lower motivation to stop smoking Promising new speech biomarker could enrich antipsychotic clinical trials Early heart disease risk factors identified in South Asian adults in the U.S. Simple wrist-worn device enables early detection of depression relapse Newsletters you may be interested in Cholesterol ( Subscribe or Preview ) Alzheimer's Disease ( Subscribe or Preview ) Diabetes ( Subscribe or Preview ) See all Newsletters » High Credibility: This website adheres to all nine standards of credibility and transparency. Medical Links Medical Home Functional Food News Health A-Z White Papers Thought Leaders Insights MediKnowledge Series Health & Personal Care Medical Devices Drugs eBooks Posters Podcasts Life Sciences Links Life Sciences Home News Lab Instruments & Equipment Life Sciences A-Z White Papers Thought Leaders Insights Webinars eBooks Posters Podcasts Other Useful Links About Meet the Team Search Newsletters Sitemap Advertise Contact Terms & Conditions Privacy & Cookie Policy Content Policy Ownership & Funding Information Other AZoNetwork Sites AZoM AZoNano AZoCleantech AZoOptics AZoRobotics AZoSensors AZoMining AZoQuantum AZoBuild AZoLifeSciences AZoAi Facebook Twitter LinkedIn News-Medical.Net provides this medical information service in accordance with these terms and conditions . Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide. Update Your Privacy Preferences Last Updated: Wednesday 11 Feb 2026 News-Medical.net - An AZoNetwork Site Owned and operated by AZoNetwork, © 2000-2026 Azthena logo with the word Azthena Maximise chat window Hide chat window Your AI Powered Scientific Assistant Hi, I'm Azthena, you can trust me to find commercial scientific answers from News-Medical.net. To start a conversation, please log into your AZoProfile account first, or create a new account. Registered members can chat with Azthena, request quotations, download pdf's, brochures and subscribe to our related newsletter content . Log in A few things you need to know before we start. Please read and accept to continue. Use of “Azthena” is subject to the terms and conditions of use as set out by OpenAI . Content provided on any AZoNetwork sites are subject to the site Terms & Conditions and Privacy Policy . Large Language Models can make mistakes. Consider checking important information. I understand, and agree to receive occasional emails about Azthena such as usage tips and new feature announcements. Please check the box above to proceed. Start Chat Great. Ask your question. Clear Chat Clear Chat Brief Moderate Detailed Azthena may occasionally provide inaccurate responses. Read the full terms . Terms While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided. Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles. Please do not ask questions that use sensitive or confidential information. Read the full Terms & Conditions . Provide Feedback Submit Cancel You might also like... × Study calls for inclusive dementia research practices in Canada